Abstract:Abstract Background Accurate mortality risk quantification is crucial for the management of hepatocellular carcinoma (HCC); however, most scoring systems are subjective. Purpose To develop and independently validate a machine learning mortality risk quantification method for HCC patients using standard-of-care clinical data and liver radiomics on baseline magnetic resonance imaging (MRI). Methods This retrospective study included all patients with multiphasic contrast-enhanced MRI at the time of diagnosis treated at our institution. Patients were censored at their last date of follow-up, end-of-observation, or liver transplantation date. The data were randomly sampled into independent cohorts, with 85% for development and 15% for independent validation. An automated liver segmentation framework was adopted for radiomic feature extraction. A random survival forest combined clinical and radiomic variables to predict overall survival (OS), and performance was evaluated using Harrell’s C-index. Results A total of 555 treatment-naïve HCC patients (mean age, 63.8 years ± 8.9 [standard deviation]; 118 females) with MRI at the time of diagnosis were included, of which 287 (51.7%) died after a median time of 14.40 (interquartile range, 22.23) months, and had median followed up of 32.47 (interquartile range, 61.5) months. The developed risk prediction framework required 1.11 min on average and yielded C-indices of 0.8503 and 0.8234 in the development and independent validation cohorts, respectively, outperforming conventional clinical staging systems. Predicted risk scores were significantly associated with OS ( p < .00001 in both cohorts). Conclusions Machine learning reliably, rapidly, and reproducibly predicts mortality risk in patients with hepatocellular carcinoma from data routinely acquired in clinical practice. Clinical relevance statement Precision mortality risk prediction using routinely available standard-of-care clinical data and automated MRI radiomic features could enable personalized follow-up strategies, guide management decisions, and improve clinical workflow efficiency in tumor boards. Key Points • Machine learning enables hepatocellular carcinoma mortality risk prediction using standard-of-care clinical data and automated radiomic features from multiphasic contrast-enhanced MRI. • Automated mortality risk prediction achieved state-of-the-art performances for mortality risk quantification and outperformed conventional clinical staging systems. • Patients were stratified into low, intermediate, and high-risk groups with significantly different survival times, generalizable to an independent evaluation cohort.

Machine learning to predict overall short-term mortality in cutaneous melanoma

Individualized melanoma risk prediction using machine learning with electronic health records

Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients

Evaluation of Machine Learning Algorithms for the Prognosis of Breast Cancer from the Surveillance, Epidemiology, and End Results Database

Breast Cancer Prognosis Using a Machine Learning Approach

Clinical Melanoma Diagnosis with Artificial Intelligence: Insights from a Prospective Multicenter Study

Deep-learning-based survival prediction of patients with cutaneous malignant melanoma

Machine learning to predict the cancer-specific mortality of patients with primary non-metastatic invasive breast cancer

Machine Learning techniques in breast cancer prognosis prediction: A primary evaluation

Current status of artificial intelligence methods for skin cancer survival analysis: a scoping review

An artificial intelligence-based model exploiting H&E images to predict recurrence in negative sentinel lymph-node melanoma patients

Artificial intelligence and skin melanoma

A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients

Predicting Prognosis of Early-Stage Mycosis Fungoides with Utilization of Machine Learning

Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care

Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning

Prediction of melanoma metastasis using dermatoscopy deep features. An international multicenter cohort study

Performance of Commercial Dermatoscopic Systems That Incorporate Artificial Intelligence for the Identification of Melanoma in General Practice: A Systematic Review

Deep Learning for Predicting Metastasis on Melanoma WSIs

Artificial intelligence-assisted metastasis and prognosis model for patients with nodular melanoma

Deep-CR MTLR: a Multi-Modal Approach for Cancer Survival Prediction with Competing Risks